SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-012515 to AMN HEALTHCARE SERVICES INC (AMN)

AMN HEALTHCARE SERVICES INC
Date: Nov. 12, 2024 · CIK: 0001142750 · Accession: 0000000000-24-012515

AI Filing Summary & Sentiment

File numbers found in text: 001-16753

Date
November 12, 2024
Author
Not clearly detected
Form
UPLOAD
Company
AMN HEALTHCARE SERVICES INC

Letter

November 12, 2024 Jeffrey R. Knudson Chief Financial Officer AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019 Re:AMN Healthcare Services, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-16753 Dear Jeffrey R. Knudson: We have reviewed your October 24, 2024 response to our comment letter and have the following comments. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our October 24, 2024 letter. Form 10-K for the Fiscal Year Ended December 31, 2023 Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations, page 26 We note your response to prior comment 3 and your belief that changes in metrics, rather than the absolutes of the metrics, are most relevant. To clarify, our prior comment sought quantification of the impact on revenue of factors to which changes are attributed, rather than quantification of the underlying metrics themselves. As an example, you attributed the change in nurse and allied solutions segment revenue to factors including changes in average number of travelers on assignment, average bill rate, and billable hours. These factors pertain to changes in price and volume. Please supplement your disclosure to quantify, in absolute dollars, the impact of factors to which changes are attributed, including changes in price, volume, and acquisitions. Refer to Item 303(b)(2)(iii) of Regulation S-K. 1.

November 12, 2024 Page 2

(j) Insurance Reserves, page 45 2.We note your response to prior comment 5. You state you provide professional liability coverage as part of your service offering to clients. You disclose in note (j) Insurance Reserves, that this expense in included in selling, general, and administrative expenses in the statement of comprehensive income. Given that professional liability coverage is part of your service offering to clients, please explain your basis for classifying the expense as SG&A rather than cost of revenue. Notes to Consolidated Financial Statements (k) Revenue Recognition, page 45 We note your response to prior comment 6. You state you record revenue on a gross basis with respect to both (a) direct staffing of locum tenens physicians, and (b) language services business’ utilization of contract interpreters. We assume, based on your disclosure on page 2, that both of these categories of revenue are derived from non-employees.

Please provide us with your analysis of principal versus agent considerations under ASC 606 for of these two categories, or non-employee portions thereof as applicable. In your response, please tell us:

•The specified goods or services (as determined from the end consumer's perspective), including your consideration of the “distinct" guidance in paragraphs 25-19 to 25-22 if there are multiple specified goods or services •The relevant contractual terms (rights and obligations) between you and both the end consumer and the other party involved in providing the specified goods or services (i.e., the supplier) •Based solely on the definition of control in paragraph 25-25 and the explanation of how control is obtained in paragraph 55-37A, your assessment of whether and how you controlled the specified goods or services before transferred to the end consumer •If control was not clear based on the above guidance and you required additional evidence to reach a control conclusion: oYour assessment of each of the following indicators of control in paragraph 55-39 and all other relevant facts and circumstances: Primary responsibility for fulfillment Inventory risk Discretion in pricing oYour assessment of whether and how evidence related to these indicators of control supported that you controlled the specified good or service before transferred to the end consumer

If there are multiple specified goods or services, provide the information in the third 3.

November 12, 2024 Page 3 and fourth bullets separately for each specified good or service. Note 1 - Summary of Significant Accounting Policies (l) Accounts Receivable,, page 46 4.We note your response to prior comment 7. In regard to the $27 million increase in the provision for credit losses for the year ended December 31, 2022, you state the portion attributed to the macroeconomic outlook is immaterial to your financial statements. As previously requested, please tell us the current status of your views with regard to uncertainty regarding other customers due to the macroeconomic outlook. Please also quantify for us the portion of the provision you recognized in 2022 related to the macroeconomic outlook at the time. Please contact Stephen Kim at 202-551-3291 or Lyn Shenk at 202-551-3380 if you have questions regarding comments on the financial statements and related matters. Sincerely, Division of Corporation Finance Office of Trade & Services

Show Raw Text
November 12, 2024
Jeffrey R. Knudson
Chief Financial Officer
AMN Healthcare Services, Inc.
2999 Olympus Boulevard, Suite 500
Dallas, TX 75019
Re:AMN Healthcare Services, Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-16753
Dear Jeffrey R. Knudson:
            We have reviewed your October 24, 2024 response to our comment letter and have
the following comments.
            Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to this letter, we may have additional comments.
Unless we note otherwise, any references to prior comments are to comments in our October
24, 2024 letter.
Form 10-K for the Fiscal Year Ended December 31, 2023
Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations, page 26
We note your response to prior comment 3 and your belief that changes in metrics,
rather than the absolutes of the metrics, are most relevant. To clarify, our prior
comment sought quantification of the impact on revenue of factors to which changes
are attributed, rather than quantification of the underlying metrics themselves. As
an example, you attributed the change in nurse and allied solutions segment revenue
to factors including changes in average number of travelers on assignment, average
bill rate, and billable hours. These factors pertain to changes in price and
volume. Please supplement your disclosure to quantify, in absolute dollars, the impact
of factors to which changes are attributed, including changes in price, volume, and
acquisitions. Refer to Item 303(b)(2)(iii) of Regulation S-K.
 1.

November 12, 2024
Page 2

(j) Insurance Reserves, page 45
2.We note your response to prior comment 5. You state you provide professional
liability coverage as part of your service offering to clients. You disclose in note (j)
Insurance Reserves, that this expense in included in selling, general, and
administrative expenses in the statement of comprehensive income. Given that
professional liability coverage is part of your service offering to clients, please explain
your basis for classifying the expense as SG&A rather than cost of revenue.
Notes to Consolidated Financial Statements
(k) Revenue Recognition, page 45
We note your response to prior comment 6. You state you record revenue on a gross
basis with respect to both (a) direct staffing of locum tenens physicians, and (b)
language services business’ utilization of contract interpreters.  We assume, based on
your disclosure on page 2, that both of these categories of revenue are derived from
non-employees.

Please provide us with your analysis of principal versus agent considerations under
ASC 606 for of these two categories, or non-employee portions thereof as applicable.
In your response, please tell us:

•The specified goods or services (as determined from the end consumer's
perspective), including your consideration of the “distinct" guidance in paragraphs
25-19 to 25-22 if there are multiple specified goods or services
•The relevant contractual terms (rights and obligations) between you and both the
end consumer and the other party involved in providing the specified goods or
services (i.e., the supplier)
•Based solely on the definition of control in paragraph 25-25 and the explanation
of how control is obtained in paragraph 55-37A, your assessment of whether and
how you controlled the specified goods or services before transferred to the end
consumer
•If control was not clear based on the above guidance and you required additional
evidence to reach a control conclusion:
oYour assessment of each of the following indicators of control in paragraph
55-39 and all other relevant facts and circumstances:
Primary responsibility for fulfillment
Inventory risk
Discretion in pricing
oYour assessment of whether and how evidence related to these indicators of
control supported that you controlled the specified good or service before
transferred to the end consumer

If there are multiple specified goods or services, provide the information in the third 3.

November 12, 2024
Page 3
and fourth bullets separately for each specified good or service.
Note 1 - Summary of Significant Accounting Policies
(l) Accounts Receivable,, page 46
4.We note your response to prior comment 7. In regard to the $27 million increase in
the provision for credit losses for the year ended December 31, 2022, you state the
portion attributed to the macroeconomic outlook is immaterial to your financial
statements. As previously requested, please tell us the current status of your views
with regard to uncertainty regarding other customers due to the macroeconomic
outlook. Please also quantify for us the portion of the provision you recognized in
2022 related to the macroeconomic outlook at the time.
            Please contact Stephen Kim at 202-551-3291 or Lyn Shenk at 202-551-3380 if you
have questions regarding comments on the financial statements and related matters.
Sincerely,
Division of Corporation Finance
Office of Trade & Services